| Stage | EOG | % of rev | NOG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $8.6B | 100.00% | $745M | 100.00% | EOG ×11.49 |
| Gross profit | $7.4B | 86.65% | $618M | 82.95% | EOG +3.7pp |
| Operating income | $3.5B | 41.21% | $353M | 47.31% | NOG +6.1pp |
| Pre-tax income | $3.5B | 40.87% | $311M | 41.68% | NOG +0.8pp |
| Net income | $2.7B | 31.81% | $237M | 31.75% | EOG +0.1pp |
| Stage | EOG | NOG | Gap · A − B |
|---|---|---|---|
| Revenue | $8.6B100.00% | $745M100.00% | EOG ×11.49 |
| Gross profit | 86.65%$7.4B | 82.95%$618M | EOG +3.7pp |
| Operating income | 41.21%$3.5B | 47.31%$353M | NOG +6.1pp |
| Pre-tax income | 40.87%$3.5B | 41.68%$311M | NOG +0.8pp |
| Net income |
| 31.81%$2.7B |
| 31.75%$237M |
| EOG +0.1pp |
No shared counterparties.